Metastatic extent-specific prognosis of women with stage IVB cervical cancer: multiple versus single distant organ involvement.

Abstract

Despite the heterogeneity of anatomical sites that metastases may affect, within the current cancer staging schematic, stage IVB encompasses all distant metastasis. This study examined survival outcomes based on the extent of distant organ metastasis in stage IVB cervical cancer. This retrospective cohort study utilized the National Cancer Institute's Surveillance, Epidemiology, and End Result Program from 2010 to 2018. The study population included 1772 women with stage IVB cervical cancer who had tumor metastasis to one or more of the following four organs: bone, brain, liver, or lung. Overall survival was assessed based on the metastatic extent in multivariable analysis. The most common metastatic site was lung (68.3%) followed by bone (35.2%), liver (30.0%), and brain (1.2%). Multiple organ metastases were seen in 26.5% of study population, with lung/liver metastases being the most frequent combination pattern (9.6%) followed by lung/bone (9.4%), and lung/bone/liver (6.4%). A total of 1442 (81.4%) deaths occurredduring the follow-up. The cohort-level median overall survival was 7months, ranging from 3months in all four organ metastases to 11months in bone metastasis alone when stratified (absolute difference 8months, P < 0.001). Multiple organ metastases were independently associated with nearly50% increased all-cause mortality risk compared to single organ metastasis (adjusted-hazard ratio 1.51, 95% CI 1.34-1.70). Survival outcomes in those with stage IVB cervical cancer with distant organ involvement can vary based on the extent of metastasis. Incorporation of single versus multiple distant organ metastasis into the cancer staging schema may be valuable (IVB1 versus IVB2).